-
Signature
-
/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael
-
Stock symbol
-
TEAM
-
Transactions as of
-
Jul 31, 2025
-
Transactions value $
-
-$1,488,563
-
Form type
-
4
-
Date filed
-
8/1/2025, 06:52 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Cannon-Brookes Michael |
CEO, Co-Founder, Director, 10%+ Owner |
C/O ATLASSIAN CORPORATION, 350 BUSH STREET, FLOOR 13, SAN FRANCISCO |
/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael |
2025-08-01 |
0001666120 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TEAM |
Class A Common Stock |
Sale |
-$297K |
-1.55K |
-0.47% |
$191.84 |
328K |
Jul 31, 2025 |
See Footnote |
F1, F2, F3 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
-$238K |
-1.23K |
-0.37% |
$194.06 |
327K |
Jul 31, 2025 |
See Footnote |
F1, F3, F4 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
-$242K |
-1.25K |
-0.38% |
$193.25 |
326K |
Jul 31, 2025 |
See Footnote |
F1, F3, F5 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
-$343K |
-1.75K |
-0.54% |
$196.01 |
324K |
Jul 31, 2025 |
See Footnote |
F1, F3, F6 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
-$349K |
-1.79K |
-0.55% |
$195.09 |
322K |
Jul 31, 2025 |
See Footnote |
F1, F3, F7 |
| transaction |
TEAM |
Class A Common Stock |
Sale |
-$19.7K |
-100 |
-0.03% |
$196.97 |
322K |
Jul 31, 2025 |
See Footnote |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: